Click it and Unblock the Notifications
Just In
Don't Miss
-
Moto G64 5G Launching in India at 12 noon Today: Check Full Specifications, Expected Pricing -
Bade Miyan Chote Miyan Box Office Collection Day 6 Prediction: Akshay’s Film Struggles To Reach 50Cr In Week 1 -
ISL 2024 Playoffs Schedule: Qualified Teams, Dates, Venues, Telecast & Live Streaming Info -
Fly For As Low As Rs 150 On Regional Connectivity Scheme Routes? -
MG Comet EV Emerges as a Trendsetter in India's Electric Vehicle Scene -
How To Keep Love Alive And Burning In A Long-Term Relationship, 8 Tips To Follow -
NEET PG 2024: Check the Registration and Exam Date Here -
Maximise Your First Indian Adventure With These Travel Tips
COVAXIN: India's first COVID-19 vaccine developed by Bharat Biotech gets nod for human trials
Hyderabad, June 30: COVAXIN, India's first vaccine against the novel coronavirus, developed by Bharat Biotech, Hyderbad-based biotechnology firm in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), gets nod from the Drug Controller General of India (DCGI) to conduct Phase I and 2 human trials.
According to the vaccine maker, human clinical trials of the experimental COVID-19 are scheduled to start across the country in July 2020. A note issued by the company says, "The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine was developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad, India."
COVAXIN™, India's 1st indigenous Covid-19 vaccine, developed by Bharat Biotech successfully enters human trials.
— BharatBiotech (@BharatBiotech) June 29, 2020
@ICMRDELHI @DBTIndia @icmr_niv #BharatBiotech #COVAXIN #covid19 #Collaboration #Indiafightscorona #makeinindia #ICMR #coronavirusvaccine pic.twitter.com/MSehntuE8d
However, there are no details on how long the next steps are likely to take and when the vaccine is likely to be launched in the market and the price of it.
Recommended Video
Several drugs have been tested for their effectiveness against COVID-19, the disease resulting from coronavirus, but they have fallen short. Gilead Sciences' remdesivir has been found to be effective in reducing the time spent in hospital by infected patients, but a cure is yet to find.
For over two decades, Bharat Biotech has been in the vanguard of creating breakthrough vaccines & therapeutics for challenging diseases.
Bharat Biotech is an Indian Biotechnology company, headquartered in Hyderabad, India. The company was founded by Indian scientist, Krishna Ella. Bharat Biotech has one of the largest pharmaceutical manufacturing plants of its kind in Asia-Pacific.
The company had earlier launched India's first indigenously developed cell culture H1N1 Swine Flu Vaccine under the brand name HNVAC.
